PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics
Go back to PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics| US BioTec Inc New Common Shares (NASDAQ: SBC) | Delayed: 2.95 -0.12 (3.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.07 | 52 Week High | $0.40 | |||
| Open | $3.08 | 52 Week Low | $0.40 | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $2.94 | EPS | $0.00 | |||
| Volume | 118,558 | |||||
